Evotec is a drug discovery and development partnership organisation and collaborates with numerous partners across the world to develop new anti-infectives. We efficiently move programs from target identification to investigational new drug (“IND”) status and have established a proven track record of contributing to the identification and characterisation of multiple anti-infective agents from pre-clinical candidates through to marketed drugs. Evotec has established a leading-edge platform enabling the discovery and development of new therapies and therapeutic approaches to treat and prevent serious and life-threatening infections. Our expertise encompasses antibacterials, antifungals, antivirals, and antiparastics. Integration, innovation Read more